Cargando…
Risk factors of lateral lymph node metastasis in cN0 papillary thyroid carcinoma
BACKGROUND: Cervical lymph node metastasis of papillary thyroid carcinoma (PTC) is common. However, whether undergoing prophylactic central lymph node (CLN) dissection or lateral lymph node (LLN) dissections to prevent metastasis is still controversial. This study aimed to retrospectively investigat...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811970/ https://www.ncbi.nlm.nih.gov/pubmed/29439716 http://dx.doi.org/10.1186/s12957-018-1336-3 |
_version_ | 1783299952153198592 |
---|---|
author | Hu, Daixing Zhou, Jing He, Wei Peng, Jie Cao, Yijia Ren, Haoyu Mao, Yu Dou, Yi Xiong, Wei Xiao, Qi Su, Xinliang |
author_facet | Hu, Daixing Zhou, Jing He, Wei Peng, Jie Cao, Yijia Ren, Haoyu Mao, Yu Dou, Yi Xiong, Wei Xiao, Qi Su, Xinliang |
author_sort | Hu, Daixing |
collection | PubMed |
description | BACKGROUND: Cervical lymph node metastasis of papillary thyroid carcinoma (PTC) is common. However, whether undergoing prophylactic central lymph node (CLN) dissection or lateral lymph node (LLN) dissections to prevent metastasis is still controversial. This study aimed to retrospectively investigate the risk factors of LLN metastasis in clinical lymph node-negative (cN0) PTC patients. METHODS: We retrospectively studied 783 lymph node-negative (cN0) PTC patients who underwent total thyroidectomy plus CLN dissection and LLN dissection. RESULTS: The rates of CLN and LLN metastases were 68.2 and 47.4%, respectively. Large tumor size (> 20 mm) had a fourfold higher risk of LLN metastasis compared with small tumor size (≤ 20 mm; OR = 4.082, 95% CI 2.646–6.289; P = 0.001). Patients with tumor in the upper lobe had ~ 3-fold higher risk of LLN metastasis compared with patients with tumor in other locations (OR = 2.874, 95% CI 1.916–4.310; P = 0.001). Multifocality and extrathyroidal extension indicated a twofold higher risk of LLN metastasis. Having ≥ 2 CLN metastases dramatically increased the risk of LLN metastasis, compared with those with < 2 CLN metastases (OR = 6.536, 95% CI 4.630–9.259; P = 0.001). CONCLUSIONS: Large tumor size (> 20 mm), tumor located in the upper lobe, multifocality, extrathyroidal extension, and ≥ 2 CLN metastases may increase the risk of LLN metastasis in cN0 PTC patients. |
format | Online Article Text |
id | pubmed-5811970 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-58119702018-02-15 Risk factors of lateral lymph node metastasis in cN0 papillary thyroid carcinoma Hu, Daixing Zhou, Jing He, Wei Peng, Jie Cao, Yijia Ren, Haoyu Mao, Yu Dou, Yi Xiong, Wei Xiao, Qi Su, Xinliang World J Surg Oncol Research BACKGROUND: Cervical lymph node metastasis of papillary thyroid carcinoma (PTC) is common. However, whether undergoing prophylactic central lymph node (CLN) dissection or lateral lymph node (LLN) dissections to prevent metastasis is still controversial. This study aimed to retrospectively investigate the risk factors of LLN metastasis in clinical lymph node-negative (cN0) PTC patients. METHODS: We retrospectively studied 783 lymph node-negative (cN0) PTC patients who underwent total thyroidectomy plus CLN dissection and LLN dissection. RESULTS: The rates of CLN and LLN metastases were 68.2 and 47.4%, respectively. Large tumor size (> 20 mm) had a fourfold higher risk of LLN metastasis compared with small tumor size (≤ 20 mm; OR = 4.082, 95% CI 2.646–6.289; P = 0.001). Patients with tumor in the upper lobe had ~ 3-fold higher risk of LLN metastasis compared with patients with tumor in other locations (OR = 2.874, 95% CI 1.916–4.310; P = 0.001). Multifocality and extrathyroidal extension indicated a twofold higher risk of LLN metastasis. Having ≥ 2 CLN metastases dramatically increased the risk of LLN metastasis, compared with those with < 2 CLN metastases (OR = 6.536, 95% CI 4.630–9.259; P = 0.001). CONCLUSIONS: Large tumor size (> 20 mm), tumor located in the upper lobe, multifocality, extrathyroidal extension, and ≥ 2 CLN metastases may increase the risk of LLN metastasis in cN0 PTC patients. BioMed Central 2018-02-13 /pmc/articles/PMC5811970/ /pubmed/29439716 http://dx.doi.org/10.1186/s12957-018-1336-3 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Hu, Daixing Zhou, Jing He, Wei Peng, Jie Cao, Yijia Ren, Haoyu Mao, Yu Dou, Yi Xiong, Wei Xiao, Qi Su, Xinliang Risk factors of lateral lymph node metastasis in cN0 papillary thyroid carcinoma |
title | Risk factors of lateral lymph node metastasis in cN0 papillary thyroid carcinoma |
title_full | Risk factors of lateral lymph node metastasis in cN0 papillary thyroid carcinoma |
title_fullStr | Risk factors of lateral lymph node metastasis in cN0 papillary thyroid carcinoma |
title_full_unstemmed | Risk factors of lateral lymph node metastasis in cN0 papillary thyroid carcinoma |
title_short | Risk factors of lateral lymph node metastasis in cN0 papillary thyroid carcinoma |
title_sort | risk factors of lateral lymph node metastasis in cn0 papillary thyroid carcinoma |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811970/ https://www.ncbi.nlm.nih.gov/pubmed/29439716 http://dx.doi.org/10.1186/s12957-018-1336-3 |
work_keys_str_mv | AT hudaixing riskfactorsoflaterallymphnodemetastasisincn0papillarythyroidcarcinoma AT zhoujing riskfactorsoflaterallymphnodemetastasisincn0papillarythyroidcarcinoma AT hewei riskfactorsoflaterallymphnodemetastasisincn0papillarythyroidcarcinoma AT pengjie riskfactorsoflaterallymphnodemetastasisincn0papillarythyroidcarcinoma AT caoyijia riskfactorsoflaterallymphnodemetastasisincn0papillarythyroidcarcinoma AT renhaoyu riskfactorsoflaterallymphnodemetastasisincn0papillarythyroidcarcinoma AT maoyu riskfactorsoflaterallymphnodemetastasisincn0papillarythyroidcarcinoma AT douyi riskfactorsoflaterallymphnodemetastasisincn0papillarythyroidcarcinoma AT xiongwei riskfactorsoflaterallymphnodemetastasisincn0papillarythyroidcarcinoma AT xiaoqi riskfactorsoflaterallymphnodemetastasisincn0papillarythyroidcarcinoma AT suxinliang riskfactorsoflaterallymphnodemetastasisincn0papillarythyroidcarcinoma |